Drug gives patients with rare tumour-causing disease hope at last - The Times
- Drug gives patients with rare tumour-causing disease hope at last The Times
- Merck Canada and the pan-Canadian Pharmaceutical Alliance (pCPA) successfully complete negotiations for WELIREG® (belzutifan) Yahoo Finance
- Adults with Von Hippel-Lindau disease to benefit from new treatment NICE
- NHS England offers MSD belzutifan for von Hippel-Lindau disease Pharmaceutical Technology
- MSD’s Welireg recommended by NICE to treat rare von Hippel-Lindau disease PMLiVE